ConductScience.org, home

Paper1369993

Complementarity of peptides specified by 'sense' and 'antisense' strands of DNA.

Blalock JE. Trends Biotechnol, 1990. Cited by 94 papers, by iCite.

Cite this record

ConductScience Library. Complementarity of peptides specified by 'sense' and 'antisense' strands of DNA. Papers, record 1369993. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1369993

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Complementarity of peptides specified by 'sense' and 'antisense' strands of DNA.
PubMed
Journal
Trends Biotechnol
PubMed
Year
1990
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
94
iCite
Relative citation ratio, by iCite
2.12
iCite
Revised in PubMed
2022-02-23
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Blalock JEJ E

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenocorticotropic HormoneMajor topic
DNA, AntisenseMajor topic
PeptidesMajor topic
Amino Acid Sequence
Animals
Base Sequence
Genetic Complementation Test
Humans
Molecular Sequence Data
RNA
Sequence Homology, Nucleic Acid

Source PubMed

Download CSV of topics

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 94 citations.

PMIDTitleJournalYearIn PapersSource
38628675The Question of HIV Vaccine: Why Is a Solution Not Yet Available?J Immunol Res2024https://conductscience.org/library/papers/38628675PubMed
34895142Biological factors in the synthetic construction of overlapping genes.BMC Genomics2021https://conductscience.org/library/papers/34895142PubMed
34502016Antisense Peptide Technology for Diagnostic Tests and Bioengineering Research.Int J Mol Sci2021https://conductscience.org/library/papers/34502016PubMed
26904499The Significance of a Common Idiotype (1F7) on Antibodies against Human Immune Deficiency Virus Type 1 and Hepatitis C Virus.Front Oncol2016https://conductscience.org/library/papers/26904499PubMed
22837805Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists.Int J Physiol Pathophysiol Pharmacol2012https://conductscience.org/library/papers/22837805PubMed
22787464Basic research in HIV vaccinology is hampered by reductionist thinking.Front Immunol2012https://conductscience.org/library/papers/22787464PubMed
22546090
Epitope reactions can be gauged by relative antibody discriminating specificity (RADS) values supported by deletion, substitution and cysteine bridge formation analyses: potential uses in pathogenesis studies.
BMC Res Notes2012https://conductscience.org/library/papers/22546090PubMed
22202003Molecular recognition theory and sense-antisense interaction: therapeutic applications in autoimmunity.Front Biosci (Elite Ed)2012https://conductscience.org/library/papers/22202003PubMed
22012269Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine.Arch Virol2012https://conductscience.org/library/papers/22012269PubMed
21670769Autoimmunity: Does autoantigen complementarity underlie PR3-ANCA AAV?Nat Rev Rheumatol2011https://conductscience.org/library/papers/21670769PubMed
18701607Antibodies with dual reactivity to plasminogen and complementary PR3 in PR3-ANCA vasculitis.J Am Soc Nephrol2008https://conductscience.org/library/papers/18701607PubMed
18043730Induction of human immunodeficiency virus (HIV-1) envelope specific cell-mediated immunity by a non-homologous synthetic peptide.PLoS One2007https://conductscience.org/library/papers/18043730PubMed
15592920Autoantigen complementarity: a new theory implicating complementary proteins as initiators of autoimmune disease.J Mol Med (Berl)2005https://conductscience.org/library/papers/15592920PubMed
15553089Gene network polymorphism is the raw material of natural selection: the selfish gene network hypothesis.J Mol Evol2004https://conductscience.org/library/papers/15553089PubMed
15008973T cell help is required to induce idiotypic-anti-idiotypic autoantibody network after immunization with complementary epitope 289-308aa of La/SSB autoantigen in non-autoimmune mice.Clin Exp Immunol2004https://conductscience.org/library/papers/15008973PubMed
10472630Directed molecular evolution.Orig Life Evol Biosph1999https://conductscience.org/library/papers/10472630PubMed
9661171The hydropathic binary code: a tool in genomic research?Nat Biotechnol1998https://conductscience.org/library/papers/9661171PubMed
9601078Translated anti-sense product of the Na/phosphate co-transporter (NaPi-II).Biochem J1998https://conductscience.org/library/papers/9601078PubMed
8510176Neutral adaptation of the genetic code to double-strand coding.J Mol Evol1993https://conductscience.org/library/papers/8510176PubMed
8378359Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8378359PubMed

See all 31 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1369993

GET https://conductscience.org/api/papers/v1/1369993/cited_by?page=2